FREE Download Special Offers

SNEEZE AND CANCER TREATMENT ON THE SAME DRUG?

serious skin cancer treatment

Can a very common allergy medicine improve survival among patients suffering from the serious skin cancer, malignant melanoma? A new study from Lund University in Sweden indicates that this may be the case.

 

Melanoma

     Melanoma is a type of skin cancer that develops when the melanocytes (the cells that give the skin its tan or brown color) start to grow out of control. Melanoma is much less common than some other types of skin cancers. But melanoma is more dangerous because it is much more likely to spread to other parts of the body if not caught and treated early.

 

 

Prof. Håkan Olsson

 

“Previous studies have shown that the same antihistamines have survival benefits in breast cancer. Now we see the same thing concerning malignant melanoma. However, more research is required to confirm the results,” emphasizes Prof. Håkan Olsson. He is one of the researchers behind the study, which was recently published in the research journal, Allergy.

 

In the study, the researchers examined the use of six antihistamines in patients diagnosed with malignant melanoma; desloratadine, cetirizine, loratadine, clemastine, ebastine and fexofenadine.

fexofenadine

clinical registries

 

They have matched information from three large clinical registries (the prescribed drug registry, cancer registry and cause of death registry) for everyone in Sweden between 2006 and 2014 who received their first diagnosis of skin cancer, a total of 24,562 individuals. Of these individuals, 1,253 were antihistamine users.

Most used desloratadine (395) cetirizine (324), loratadine (251) or clemastine (192).The other antihistamines were used by considerably fewer individuals. The follow-up of individuals was carried out on 31 December 2018.

“We observed improved survival among those who used desloratadine and to a certain extent also loratadine, particularly in the age group 65 and older, when we compared with those who had not used antihistamines. The use of the other antihistamines showed no significant survival effect. The use of desloratadine and loratadine also seemed to reduce the risk of getting a new malignant melanoma,” says Prof. Håkan Olsson.

“The finding is interesting for a future drug against melanoma and may also help in advanced stages of the disease. In addition, the medicines have virtually no side effects.”The research team is now planning animal experiments and randomized studies in order to understand the mechanisms behind the effect, the appropriate dose and optimum treatment period.

“We are collaborating with researchers in Barcelona and Stockholm. In Lund, we are underway with studies in both animal and human subjects, in which doses of antihistamines will be compared with the patients who do not take antihistamines, in order to measure the treatment effect,” concludes Prof. Håkan

 

REFERENCE

1. Lund University. (2020, May 11). Antihistamines may help patients with malignant melanoma. ScienceDaily. Retrieved May 17, 2020 from https://www.sciencedaily.com/releases/2020/05/200511112616.htm

2. Eurekalert. (2020, May 14). “Allergy Medications May Treat Malignant Melanoma Patients”. Medindia. Retrieved May 17, 2020 from https://www.medindia.net/news/antihistamines-may-help-patients-with-malignant-melanoma-194948-1.htm

3. American Cancer Society. (n.d.). “What Is Melanoma Skin Cancer?” Retrieved May 17, 2020 from https://www.cancer.org/cancer/melanoma-skin-cancer/about/what-is-melanoma.html
#references

 

IMAGE GLOSSARY

1. https://www.google.com/url?sa=i&url=https%3A%2F%2Fwww.express.co.uk%2Flife-style%2Fhealth%2F1150640%2Fskin-cancer-signs-melanoma-symptoms-mole&psig=AOvVaw3cXQ_gNh7MKWxIEDPyyQaD&ust=1590677 603838000&source=images&cd=vfe&ved=0CAIQjRxqFwoTCKDN7uWs1OkCFQAAAAAdAAAAABAD

2. https://www.google.com/url?sa=i&url=https%3A%2F%2Fwww.miragenews.com%2Fantihistamines-may-help-patients-with-malignant-melanoma%2F&psig=AOvVaw1t_IqokHJMuNxTXfcZ1FO7&ust=1590676358415000&source=i mages&cd=vfe&ved=0CAIQjRxqFwoTCOivw_Ss1OkCFQAAAAAdAAAAABAD

3. https://www.google.com/url?sa=i&url=https%3A%2F%2Fwww.shutterstock.com%2Fimage-photo%2Fkyiv-ukrainemay-27-2019-loratadine-medication-1408679642&psig=AOvVaw3B_mEOlpOjRMdWY80TXFef&ust=159067810 7185000&source=images&cd=vfe&ved=0CAIQjRxqFwoTCJDH4Yut1OkCFQAAAAAdAAAAABAX

4. https://www.google.com/url?sa=i&url=https%3A%2F%2Fwww.shutterstock.com%2Fimage-photo%2Fkyiv-ukrainemay-25-2019-fexofenadine-medication-1406925812&psig=AOvVaw3B_mEOlpOjRMdWY80TXFef&ust=1590678 107185000&source=images&cd=vfe&ved=0CAIQjRxqFwoTCJDH4Yut1OkCFQAAAAAdAAAAABAc

5. https://www.google.com/url?sa=i&url=https%3A%2F%2Fwww.pinterest.com%2Fpin%2F330381322648811707%2F&psig=AOvVaw3B_mEOlpOjRMdWY80TXFef&ust=1590678107185000&source=images&cd=vfe&ved=0CAIQjRx qFwoTCJDH4Yut1OkCFQAAAAAdAAAAABAn

6. https://www.google.com/url?sa=i&url=https%3A%2F%2Fwww.news-medical.net%2Fhealth%2FLong-Term-Effects-of-Taking-Allergy-Medications.aspx&psig=AOvVaw3B_mEOlpOjRMdWY80TXFef&ust=1590678107185000&source=i mages&cd=vfe&ved=0CAIQjRxqFwoTCJDH4Yut1OkCFQAAAAAdAAAAABBX

Spread the love

Comments

Enter License Information





Please check the box if you agree with the statement

APRN world strongly encourage the participant to consult with their respective nursing board/employer or regulatory agency regarding the specific requirement for posttest activity as part of their nursing continuing professional education. APRN world does not require however, strongly recommend candidates to attend the posttest activity

Click to Proceed

Please check the box if you agree with the statement

APRN world strongly encourage the participant to consult with their respective nursing board/employer or regulatory agency regarding the specific requirement for posttest activity as part of their nursing continuing professional education. APRN world does not require however, strongly recommend candidates to attend the posttest activity.

I hereby acknowledge my explicit desire to proceed with the completion of the nursing continuing professional development course provided by APRN world without recommended posttest activity. I assume all responsibility of any consequences related to satisfying the specific board of nursing requirements because of this action. I will keep APRN world away from any liability related to such issues.

Click to Confirm

🔔 Important Update: We’ve moved to a new learning portal! From May 3rd, all new purchases of Basic Arrhythmia and Advanced Arrhythmia courses must be accessed through the new portal

X